• Skip to main content

DistilINFO LifeSciences

Weekly round up from Life Sciences Industry.

  • Publications
    • Home
    • DistilINFO HealthPlan
    • DistilINFO HospitalIT
    • DistilINFO IT
    • DistilINFO Retail
    • DistilINFO POPHealth
    • DistilINFO Ageing
    • DistilINFO Life Sciences
    • DistilINFO GovHealth
    • DistilINFO EHS
    • DistilINFO HealthIndia
    • Subscribe
    • Submit Article
    • Advertise
    • Newsletters

Germany Introduces Digital Supply Act to Digitalise Healthcare

Share:

November 19, 2019

Health minister Jens Spahn defended the new legislation against concerns about the use of patient data for medical research.

The Digital Supply Law (DVG), which was proposed by minister of health Jens Spahn earlier this year, was passed by the parliament on 8 November.

Under the new legislation, doctors will be able to prescribe digital health apps to patients, which can be reimbursed by the country’s statutory health insurance. App providers will have to prove to the federal Institute for Drugs and Medical Devices (BfArM) that their apps can improve patient care.

Also, doctors will be able to receive money for providing online consultation to patients with statutory insurance. Doctors will be allowed to provide information about video and online consultations on their websites, whereas before they had only been able to discuss these in private conversations.

Want to publish your own articles on DistilINFO Publications?

Send us an email, we will get in touch with you.

The legislation also aims to phase out the use of paper by promoting e-prescriptions and providing doctors with higher reimbursement for sending electronic medical letters than for faxes. Germany also plans to bring in electronic health records (EHRs) for patients with statutory insurance by 2021.

However patient advocates have complained that the act does not allow patients to opt out of having their data shared for research purposes.

The act allows billing data from health insurance funds to be used by authorities, research institutes or university hospitals without prior consent for research purposes. This includes patient information such as age, gender, place of residence, health status and treatments.

Patient data will be transmitted in pseudonymised form and stored at a central data point. Spahn said the data will also be anonymised for research purposes to prevent the possibility of tracing and identification.

WHY IT MATTERS

Germany is the world’s second largest healthcare market after the United States, spending around €374bn annually. However up until recently it has one of the lowest digitisation levels among developed countries.

The act is an attempt for Germany to expand the digitalisation of its health services after years of stagnation.

THE LARGER TREND

Around 73 million people are under Germany’s statutory insurance system, representing 90% of the population.

In April, Spahn officially launched the Health Innovation Hub (HIH), to drive the digital transformation of Germany’s healthcare system. International digitalisation was set as the top priority for the new initiative.

ON THE RECORD

Speaking on the German breakfast TV show, ZDF Morgenmagazin last week, Spahn called the prescription of health apps under the Digital Supply Act a “world first”.

Responding to privacy concerns, Spahn said: “It is about making health research possible in order to get better insight into patients with chronic diseases such as diabetes.”

Source: Healthcare IT News

Coffee with DistilINFO's Morning Updates...

Sign up for DistilINFO e-Newsletters.

Just a little bit more about you...
PROCEED
Choose Lists
BACK

Related Stories

  • Vir Biotechnology and Biogen Execute Agreement to Manufacture SARS-CoV-2 Antibodies for Potential COVID-19 TreatmentVir Biotechnology and Biogen Execute Agreement to Manufacture SARS-CoV-2 Antibodies for Potential COVID-19 Treatment
  • 3D Printed Drugs Market to Reach US$ 2,064.8 Million by 2027 Globally | CAGR: 15.2%3D Printed Drugs Market to Reach US$ 2,064.8 Million by 2027 Globally | CAGR: 15.2%
  • Humacyte, a Transformative Biotechnology Platform Company Capable of Manufacturing Universally Implantable Bioengineered Human Tissue at Commercial Scale, Going Public via Merger with Alpha Healthcare Acquisition Corp.Humacyte, a Transformative Biotechnology Platform Company Capable of Manufacturing Universally Implantable Bioengineered Human Tissue at Commercial Scale, Going Public via Merger with Alpha Healthcare Acquisition Corp.
  • Brightinsight & UCB Partner to Build Digital Care Solutions for Rare DiseasesBrightinsight & UCB Partner to Build Digital Care Solutions for Rare Diseases
  • Fitbit, Scripps, Stanford to Study Role of Wearables to Detect, Train, and Contain Infectious DiseasesFitbit, Scripps, Stanford to Study Role of Wearables to Detect, Train, and Contain Infectious Diseases
  • LHC Group, Texas Health Resources, and Methodist Health System Expand Partnership with Purchase of Arlington Home Health AgencyLHC Group, Texas Health Resources, and Methodist Health System Expand Partnership with Purchase of Arlington Home Health Agency
  • Cross Country Healthcare Merges Permanent Search Recruitment Brands, Introduces Cross Country SearchCross Country Healthcare Merges Permanent Search Recruitment Brands, Introduces Cross Country Search
  • Deloitte Working With Amazon Web Services to Create New Health Ecosystems Through DataDeloitte Working With Amazon Web Services to Create New Health Ecosystems Through Data

Trending This Week

Sorry. No data so far.

About Us

DistilINFO is media company that publishes Industry news, views and Interviews. We distil the information for you – saving time and keeping you up to date on your interest areas.

More About Us

Follow Us


Useful Links

  • Subscribe
  • Contact
  • Advertise
  • Privacy Policy
  • Terms of Service
  • Feedback

All Publications

  • DistilINFO HealthPlan Advisory
  • DistilINFO HospitalIT Advisory
  • DistilINFO IT Advisory
  • DistilINFO Retail Advisory
  • DistilINFO POPHealth Advisory
  • DistilINFO Ageing Advisory
  • DistilINFO Life Sciences Advisory
  • DistilINFO GovHealth Advisory
  • DistilINFO EHS Advisory
  • DistilINFO HealthIndia Advisory

© DistilINFO Publications